| RS139401491 |
SOS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Noonan syndrome 9, Cardiovascular phenotype |
| RS1394015094 |
BBS7
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome |
| RS139401671 |
FZD4
|
Health Risk |
Pathogenic |
— |
| RS1394017906 |
MEN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Multiple endocrine neoplasia, type 1 |
| RS139402062 |
FHL1
|
Health Risk |
Conflicting classifications of pathogenicity |
X-linked myopathy with postural muscle atrophy, Cardiovascular phenotype |
| RS1394021280 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS1394021695 |
PCLO
|
Health Risk |
Pathogenic |
— |
| RS139402633 |
TULP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, Leber congenital amaurosis 15 |
| RS139403702 |
SCN1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Generalized epilepsy with febrile seizures plus, type 2 |
| RS1394044603 |
MUTYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 2 |
| RS139405076 |
RNF43
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyperplastic polyposis syndrome, Hyperplastic polyposis syndrome |
| RS139405380 |
ZMYM3
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1394059438 |
RYR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Catecholaminergic polymorphic ventricular tachycardia 1, Arrhythmogenic right ventricular dysplasia 2 |
| RS1394059699 |
DSG2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiomyopathy, Arrhythmogenic right ventricular dysplasia 10 |
| RS1394064043 |
RPL5
|
Health Risk |
Likely pathogenic |
Diamond-Blackfan anemia 6, Glioma susceptibility 1 |
| RS139406689 |
ERCC4
|
Health Risk |
Conflicting classifications of pathogenicity |
Xeroderma pigmentosum, group F |
| RS139407102 |
RAB3GAP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Martsolf syndrome, Warburg micro syndrome 2 |
| RS139407103 |
ADCY3
|
Health Risk |
Conflicting classifications of pathogenicity |
ADCY3-related disorder, ADCY3-related disorder |
| RS139407567 |
AIP
|
Health Risk |
Conflicting classifications of pathogenicity |
Somatotroph adenoma, Hereditary cancer-predisposing syndrome |
| RS1394080480 |
FBXL4
|
Health Risk |
Pathogenic |
Mitochondrial DNA depletion syndrome 13, Mitochondrial DNA depletion syndrome 13 |
| RS139408872 |
SLC34A3
|
Health Risk |
Pathogenic |
Autosomal recessive hypophosphatemic bone disease, Autosomal recessive hypophosphatemic bone disease |
| RS139409005 |
CDH23
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS139409128 |
RYR1
|
Health Risk |
Conflicting classifications of pathogenicity |
RYR1-related disorder, Congenital multicore myopathy with external ophthalmoplegia |
| RS1394098762 |
CLCN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital myotonia, autosomal recessive form |
| RS1394101107 |
ABCA4
|
Health Risk |
Likely pathogenic |
— |
| RS139410488 |
ASL
|
Health Risk |
Conflicting classifications of pathogenicity |
Argininosuccinate lyase deficiency, Argininosuccinate lyase deficiency |
| RS139411571 |
FRMD7
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS139411595 |
DYSF
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Autosomal recessive limb-girdle muscular dystrophy type 2B |
| RS1394116781 |
SYNE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive ataxia, Beauce type |
| RS139412383 |
SLC2A1
|
Health Risk |
Conflicting classifications of pathogenicity |
GLUT1 deficiency syndrome 1, autosomal recessive |
| RS139412411 |
FRAS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Fraser syndrome 1, Fraser syndrome 1 |
| RS139412425 |
IL17RA
|
Health Risk |
Conflicting classifications of pathogenicity |
Immunodeficiency 51, Immunodeficiency 51 |
| RS139412622 |
LAMA5
|
Health Risk |
Conflicting classifications of pathogenicity |
LAMA5-related disorder, LAMA5-related disorder |
| RS139412672 |
KIAA1549
|
Health Risk |
Conflicting classifications of pathogenicity |
KIAA1549-related disorder, Inborn genetic diseases |
| RS1394131270 |
SZT2
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1394131775 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1394135402 |
SGCG
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2C, Autosomal recessive limb-girdle muscular dystrophy type 2C |
| RS1394140383 |
COL4A4
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive Alport syndrome, Hematuria |
| RS1394141324 |
SPTA1
|
Health Risk |
Pathogenic |
Pyropoikilocytosis, hereditary |
| RS139414606 |
PMS1
|
Health Risk |
Likely pathogenic |
Ovarian cancer, Ovarian cancer |
| RS139415150 |
POMT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B1 |
| RS139415563 |
CEP290
|
Health Risk |
Conflicting classifications of pathogenicity |
Meckel syndrome, type 4 |
| RS139415581 |
CYP27A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Cholestanol storage disease, CYP27A1-related disorder |
| RS1394158081 |
MAK
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa 62, Retinitis pigmentosa 62 |
| RS139416233 |
DNAAF2
|
Health Risk |
Pathogenic/Likely pathogenic |
Primary ciliary dyskinesia, DNAAF2-related disorder |
| RS139416272 |
RGS3
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS139416487 |
TEX14
|
Health Risk |
Likely pathogenic |
Non-obstructive azoospermia, Non-obstructive azoospermia |
| RS139416718 |
OTOF
|
Health Risk |
Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 9, Nonsyndromic genetic hearing loss |
| RS139417458 |
PEX12
|
Health Risk |
Conflicting classifications of pathogenicity |
Peroxisome biogenesis disorder 3A (Zellweger), PEX12-related disorder |
| RS139417576 |
CASR
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial hypocalciuric hypercalcemia, Autosomal dominant hypocalcemia 1 |
| RS139418141 |
ADGRE2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS139418651 |
CDK13
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1394188143 |
PYGM
|
Health Risk |
Conflicting classifications of pathogenicity |
Glycogen storage disease, type V |
| RS139418842 |
FLCN
|
Health Risk |
Conflicting classifications of pathogenicity |
Birt-Hogg-Dube syndrome, Hereditary cancer-predisposing syndrome |
| RS139418917 |
NECTIN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Cleft lip/palate-ectodermal dysplasia syndrome, Cleft lip/palate-ectodermal dysplasia syndrome |
| RS1394193524 |
ALMS1
|
Health Risk |
Likely pathogenic |
Alstrom syndrome, Alstrom syndrome |
| RS139419737 |
RD3
|
Health Risk |
Conflicting classifications of pathogenicity |
Leber congenital amaurosis 12, Retinal dystrophy |
| RS1394199064 |
KIF1B
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS1394199299 |
MET
|
Health Risk |
Conflicting classifications of pathogenicity |
Renal cell carcinoma, Hereditary cancer-predisposing syndrome |
| RS1394225411 |
HCN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Early-infantile DEE, Early-infantile DEE |
| RS1394227134 |
C2
|
Health Risk |
Pathogenic |
— |
| RS1394231995 |
MYH9
|
Health Risk |
Conflicting classifications of pathogenicity |
Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss, Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss |
| RS139423939 |
SPG11
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia 11, Inborn genetic diseases |
| RS1394246954 |
AFG2A
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder, Neurodevelopmental disorder |
| RS1394251620 |
ALPK1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS139425340 |
ALMS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Alstrom syndrome, Cardiovascular phenotype |
| RS139425622 |
ACADVL
|
Health Risk |
Pathogenic |
Very long chain acyl-CoA dehydrogenase deficiency, Very long chain acyl-CoA dehydrogenase deficiency |
| RS139425890 |
GNE
|
Health Risk |
Pathogenic/Likely pathogenic |
GNE myopathy, Sialuria |
| RS139426093 |
TRRAP
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental disorder, Developmental disorder |
| RS139426141 |
PADI3
|
Health Risk |
Conflicting classifications of pathogenicity |
Central centrifugal cicatricial alopecia, Uncombable hair syndrome 1 |
| RS1394266353 |
GCK
|
Health Risk |
Pathogenic |
Maturity-onset diabetes of the young, GCK-related disorder |
| RS139427451 |
SETX
|
Health Risk |
Conflicting classifications of pathogenicity |
Amyotrophic lateral sclerosis type 4, Spinocerebellar ataxia |
| RS1394276163 |
USH1G
|
Health Risk |
Conflicting classifications of pathogenicity |
Usher syndrome type 1G, Usher syndrome type 1G |
| RS139428059 |
RNF213
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS139428175 |
FBN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital contractural arachnodactyly, Congenital contractural arachnodactyly |
| RS139428176 |
KRT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Diffuse nonepidermolytic palmoplantar keratoderma, Epidermolytic ichthyosis |
| RS139428292 |
RBM8A
|
Health Risk |
Conflicting classifications of pathogenicity; other |
Radial aplasia-thrombocytopenia syndrome, RBM8A-related disorder |
| RS139429793 |
EGFR
|
Health Risk |
Conflicting classifications of pathogenicity |
Lung adenocarcinoma, EGFR-related lung cancer |
| RS139429887 |
GABBR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Epileptic encephalopathy, Inborn genetic diseases |
| RS1394300572 |
LHCGR
|
Health Risk |
Likely pathogenic |
— |
| RS1394301488 |
CHRNA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant nocturnal frontal lobe epilepsy, Autosomal dominant nocturnal frontal lobe epilepsy 4 |
| RS139430866 |
GFM1
|
Health Risk |
Pathogenic/Likely pathogenic |
Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1, Combined oxidative phosphorylation deficiency |
| RS139431568 |
PHKB
|
Health Risk |
Conflicting classifications of pathogenicity |
Glycogen storage disease IXb, Glycogen storage disease IXb |
| RS1394324745 |
LRPPRC
|
Health Risk |
Pathogenic |
— |
| RS139432673 |
FLG
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1394331445 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS139433219 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS139433990 |
NEK1
|
Health Risk |
Conflicting classifications of pathogenicity |
Short-rib thoracic dysplasia 6 with or without polydactyly, NEK1-related disorder |
| RS139434026 |
APOB
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypercholesterolemia, familial |
| RS139434755 |
COL7A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Epidermolysis bullosa dystrophica, Epidermolysis bullosa dystrophica |
| RS139434937 |
PALLD
|
Health Risk |
Conflicting classifications of pathogenicity |
Pancreatic cancer, susceptibility to |
| RS1394349467 |
CHD8
|
Health Risk |
Likely pathogenic |
Intellectual developmental disorder with autism and macrocephaly, Intellectual developmental disorder with autism and macrocephaly |
| RS1394353328 |
ASPM
|
Health Risk |
Pathogenic |
— |
| RS139435501 |
CCDC40
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia, Primary ciliary dyskinesia 15 |
| RS139435774 |
MAN2B1
|
Health Risk |
Conflicting classifications of pathogenicity |
Deficiency of alpha-mannosidase, Deficiency of alpha-mannosidase |
| RS1394361948 |
RET
|
Health Risk |
Conflicting classifications of pathogenicity |
Multiple endocrine neoplasia, type 2 |
| RS139436386 |
VPS13B
|
Health Risk |
Conflicting classifications of pathogenicity |
Cohen syndrome, Inborn genetic diseases |
| RS139436396 |
C1QTNF5;MFRP
|
Health Risk |
Conflicting classifications of pathogenicity |
Late-onset retinal degeneration, Isolated microphthalmia 5 |
| RS139436724 |
NBAS
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1394368004 |
VPS13A
|
Health Risk |
Pathogenic |
— |